Georgios T Stathopoulos Selected Research

Urethane (Ethyl Carbamate)

10/2018	Geminin ablation in vivo enhances tumorigenesis through increased genomic instability.
1/2018	The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
1/2018	p52 expression enhances lung cancer progression.
1/2018	IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma.
1/2016	Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer.
4/2012	Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.
12/2011	A critical role for macrophages in promotion of urethane-induced lung carcinogenesis.
12/2011	Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice.
8/2010	Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice.
11/2007	Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georgios T Stathopoulos Research Topics

Disease

51	Neoplasms (Cancer) 03/2022 - 05/2005
15	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2007
13	Carcinogenesis 01/2021 - 11/2007
12	Malignant Pleural Effusion 04/2019 - 02/2006
11	Adenocarcinoma of Lung 01/2022 - 03/2008
11	Inflammation (Inflammations) 01/2019 - 02/2007
10	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2008
4	Adenocarcinoma 06/2015 - 01/2008
4	Fibrosis (Cirrhosis) 05/2011 - 01/2005
4	Pneumonia (Pneumonitis) 05/2011 - 11/2005
4	Pleural Effusion (Pleural Effusions) 07/2009 - 06/2005
3	Colonic Neoplasms (Colon Cancer) 10/2018 - 04/2015
3	Hyperplasia 10/2018 - 08/2010
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2011 - 04/2005
3	Eosinophilia 08/2010 - 06/2005
3	Lewis Lung Carcinoma 03/2010 - 03/2008
2	Malignant Mesothelioma 01/2022 - 11/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2017
2	Lung Diseases (Lung Disease) 02/2019 - 01/2019
2	Adenoma (Adenomas) 10/2018 - 08/2010
2	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2017
2	Cachexia 05/2011 - 03/2009
2	Weight Loss (Weight Reduction) 05/2011 - 11/2005
2	Pleural Diseases 01/2011 - 10/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2008 - 11/2007
1	Bronchiectasis 12/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Dehydration (Water Stress) 01/2021
1	Bronchiolitis 02/2019
1	Lung Injury 01/2019
1	Carcinoma (Carcinomatosis) 10/2018
1	Genomic Instability 10/2018

Drug/Important Bio-Agent (IBA)

10	ChemokinesIBA 03/2022 - 01/2009
10	Urethane (Ethyl Carbamate)IBA 10/2018 - 11/2007
8	CarcinogensIBA 01/2021 - 04/2012
8	Proteins (Proteins, Gene)FDA Link 08/2020 - 02/2007
6	LigandsIBA 03/2022 - 04/2012
6	CytokinesIBA 12/2017 - 10/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 02/2007
6	NF-kappa B (NF-kB)IBA 03/2010 - 02/2006
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	OsteopontinIBA 12/2020 - 07/2009
4	Interleukin-5 (Interleukin 5)IBA 04/2015 - 06/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 02/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 05/2011 - 01/2005
4	CollagenIBA 05/2011 - 01/2005
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2008
3	SmokeIBA 01/2021 - 06/2017
3	Pharmaceutical PreparationsIBA 11/2020 - 03/2010
3	Biological ProductsIBA 01/2018 - 04/2015
3	Bortezomib (Velcade)FDA Link 01/2016 - 03/2010
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022 - 01/2015
2	AsbestosIBA 01/2022 - 05/2005
2	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2020
2	CateninsIBA 01/2020 - 11/2019
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 12/2011
2	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 11/2005
2	InterleukinsIBA 01/2018 - 06/2005
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2017 - 01/2016
2	Liposomes (Liposome)IBA 05/2017 - 12/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2012 - 03/2010
1	protein-S-isoprenylcysteine O-methyltransferaseIBA 03/2022
1	deltarasinIBA 03/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2022
1	Chemokine ReceptorsIBA 03/2022
1	cysmethynilIBA 03/2022
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 03/2022
1	NitrilesIBA 12/2021
1	Cathepsin CIBA 12/2021
1	brensocatibIBA 12/2021
1	Peptide Hydrolases (Proteases)FDA Link 12/2021
1	Versicans (Versican)IBA 01/2021
1	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 01/2021
1	InterferonsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 08/2020
1	indolepropanol phosphate (IPP)IBA 08/2020
1	integrin-linked kinaseIBA 08/2020
1	PlatinumIBA 08/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	ProlactinIBA 11/2019
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2019
1	AzoxymethaneIBA 10/2018
1	Hematoxylin (Haematoxylon)IBA 10/2018
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2018
1	Dextrans (Dextran)FDA Link 10/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2018
1	GemininIBA 10/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018

Therapy/Procedure

6	Therapeutics 03/2022 - 04/2010
2	Immunotherapy 01/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 08/2020 - 01/2018
2	Radiotherapy 01/2018 - 04/2010
2	Intravenous Injections 04/2015 - 03/2008
2	Chemoprevention 12/2011 - 11/2007
1	Fluid Therapy (Oral Rehydration Therapy) 01/2021
1	Catheters 04/2019
1	Lung Transplantation 02/2019